Trans fat involvement in cardiovascular disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing in vitro, animal, and epidemiological research without systematic methodology.
PubMed 22760981 · doi:10.1002/mnfr.201100700
What was done
This narrative review synthesized recent in vitro, animal, and epidemiological studies examining the mechanisms and effects of dietary trans fatty acids (TFAs) on cardiovascular disease and atherosclerosis, comparing industrial trans fatty acids (iTFAs) with ruminant trans fats (rTFAs).
What was found
The abstract provides no numerical data or effect sizes. It reports that epidemiological evidence links TFA and iTFA intake to atherosclerosis and cardiovascular complications, whereas emerging research suggests rTFAs may play a cardioprotective role, through largely unknown molecular mechanisms.
Why it matters
It highlights an important potential distinction between industrial and ruminant trans fats in cardiovascular risk.
Limits
The abstract contains no quantitative metrics, sample sizes, or search criteria. As a narrative review relying partly on preclinical models and observational associations, causal certainty is limited.
Cited by
- supports Trans fatty acids stiffen cell membranes, including endothelial cells.